Cargando…

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

BACKGROUND: The emergence and spread of high levels of HIV-1 drug resistance in resource-limited settings where combination antiretroviral treatment has been scaled up could compromise the effectiveness of national HIV treatment programmes. We aimed to estimate changes in the prevalence of HIV-1 dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ravindra K, Jordan, Michael R, Sultan, Binta J, Hill, Andrew, Davis, Daniel HJ, Gregson, John, Sawyer, Anthony W, Hamers, Raph L, Ndembi, Nicaise, Pillay, Deenan, Bertagnolio, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Publishing Group 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790969/ https://www.ncbi.nlm.nih.gov/pubmed/22828485 http://dx.doi.org/10.1016/S0140-6736(12)61038-1

Ejemplares similares

Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review
por: Hamers, Raph L, et al.
Publicado: (2022)

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2018)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Initiating the antiretroviral therapy in treatment-naïve patients
por: Benea, Elisabeta, et al.
Publicado: (2014)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women
por: Huntington, Susie, et al.
Publicado: (2014)

The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study
por: Hontelez, Jan A. C., et al.
Publicado: (2016)

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
por: Phillips, Andrew N, et al.
Publicado: (2020)

The population-level impact of public-sector antiretroviral therapy rollout on adult mortality in rural Malawi
por: Payne, Collin F., et al.
Publicado: (2017)

Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications
por: Wilson, Herieth Ismael, et al.
Publicado: (2020)

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
por: Ekong, Ernest, et al.
Publicado: (2020)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children
por: Idris, Nikmah S., et al.
Publicado: (2016)

Factors influencing global antiretroviral procurement prices
por: Wirtz, Veronika J, et al.
Publicado: (2009)

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study
por: Gregson, John, et al.
Publicado: (2016)

Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1
por: Titanji, Boghuma Kabisen, et al.
Publicado: (2017)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
por: Li, Min, et al.
Publicado: (2023)

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
por: Kemp, Steven A., et al.
Publicado: (2022)

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration
por: Kantor, Rami, et al.
Publicado: (2005)

Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011)

Antiretroviral therapy needs: the effect of changing global guidelines
por: Stanecki, Karen, et al.
Publicado: (2010)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Comparison of Time to Viral Suppression Among Treatment-Naïve HIV-Infected Adults Initiating Combination Antiretroviral Therapy by Antiretroviral Regimen Class
por: Jacobson, Karen, et al.
Publicado: (2017)

Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy
por: Harries, Anthony D., et al.
Publicado: (2016)

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Using geospatial modeling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa
por: Gerberry, David J., et al.
Publicado: (2014)

Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohort
por: Silva, C, et al.
Publicado: (2010)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
por: Waning, Brenda, et al.
Publicado: (2010)

Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment
por: Chahal, Harinder Singh, et al.
Publicado: (2018)

Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study
por: Sinha, Sanjeev, et al.
Publicado: (2013)

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
por: Ndembi, Nicaise, et al.
Publicado: (2020)

The next generation of the World Health Organization's global antiretroviral guidance
por: Hirnschall, Gottfried, et al.
Publicado: (2013)

In what ways do communities support optimal antiretroviral treatment in Zimbabwe?
por: Scott, K., et al.
Publicado: (2014)

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis
por: Cruciani, Mario, et al.
Publicado: (2019)

Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients
por: Chakravarty, Jaya, et al.
Publicado: (2012)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_csd9jmh318uqpj075gncf3rabi